Kidney disease in the cardiac catheterization laboratory : a practical approach /
Saved in:
Imprint: | Cham, Switzerland : Springer, 2020. |
---|---|
Description: | 1 online resource |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12607138 |
Table of Contents:
- Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes
- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions
- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
- Cardiovascular impact of Atherosclerotic Renovascular Disease
- Platelet Function testing and antiplatelet agent choice in CKD
- Choice of stents and clinical outcomes in patients with CKD
- Revascularization strategies in CKD: PCI vs CABG
- Approach to revascularization in the potential kidney transplant recipient
- Nephrology consultative approach and risk stratification prior to revascularization in CKD
- Contrast Induced AKI: Epidemiology, risk stratification and prognosis
- Contrast induced AKI: Pathophysiological Mechanisms
- Prevention of Contrast Induced AKI: Summary of volume optimization strategies
- Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practices
- Intra procedural and operator strategies for reduction of contrast induced AKI
- Effect of Percutaneous Ventricular Assist Devices on Renal Function
- Renal athero-embolic disease: An underdiagnosed entity
- Acute kidney injury with trans catheter aortic valve replacement
- Impact of kidney disease in catheter based mitral valve interventions
- Acute kidney injury with peripheral vascular interventions
- Renal Artery Stenosis: State of the Art in Diagnosis and Management
- Renal Denervation: Physiology, scope and current evidence
- Economic impact of AKI and CKD in cardiac interventions
- Biomarkers in early risk stratification and management of post catheterization AKI
- Utilization of the cardio nephrology collaborative in the era of value based medicine.